The pathogenesis of chagasic cardiomyopathy is not completely understood, but it has been correlated with parasympathetic denervation (neurogenic theory) and inflammatory activity (immunogenic theory) that could affect heart muscarinic acetylcholine receptor (mAChR) expression. In order to further understand whether neurogenic and/or immunogenic alterations are related to changes in mAChR expression, we studied two models of Trypanosoma cruzi infection: 1) in 3-week-old male Sprague Dawley rats chronically infected with T. cruzi and 2) isolated primary cardiomyocytes co-cultured with T. cruzi and peripheral blood mononuclear cells (PBMC). Using [ 3 H]-quinuclidinylbenzilate ([ 3 H]-QNB) binding assays, we evaluated mAChR expression in homogenates from selected cardiac regions, PBMC, and cultured cardiomyocytes. We also determined in vitro protein expression and pro-inflammatory cytokine expression in serum and cell culture medium by ELISA. Our results showed that: 1) mAChR were significantly (P < 0.05) up-regulated in right ventricular myocardium (means ± SEM; control: 58.69 ± 5.54, N = 29; Chagas: 72.29 ± 5.79 fmol/mg, N = 34) and PBMC (control: 12.88 ± 2.45, N = 18; Chagas: 20.22 ± 1.82 fmol/mg, N = 19), as well as in cardiomyocyte transmembranes cultured with either PBMC/T. cruzi co-cultures (control: 24.33 ± 3.83; Chagas: 43.62 ± 5.08 fmol/mg, N = 7 for both) or their conditioned medium (control: 37.84 ± 3.84, N = 4; Chagas: 54.38 ± 6.28 fmol/mg, N = 20); 2) [ 3 H]-leucine uptake was increased in cardiomyocytes co-cultured with PBMC/T. cruzi-conditioned medium (Chagas: 21,030 ± 2321; control 10,940 ± 2385 dpm, N = 7 for both; P < 0.05); 3) plasma IL-6 was increased in chagasic rats, IL-1β was increased in both plasma of chagasic rats and in the culture medium, and TNF-α level was decreased in the culture medium. In conclusion, our results suggest that cytokines are involved in the up-regulation of mAChR in chronic Chagas disease. 
Introduction
Chagas disease is caused by the parasitic protozoan Trypanosoma cruzi, which is transmitted to humans by various species of the bloodsucking insects of the Reduvidae family. Chagas disease is endemic in 21 countries of the Americas and currently there are more than 17 million infected people with 100 million more expected to become infected in the next decade. It is estimated that 1 million new cases are developed per year with 45,000 deaths per year due to advanced disease (1) .
In Venezuela, Chagas disease is a public health problem, affecting mainly people living in rural areas under poor sanitary conditions (2) . The heart is one of the organs most frequently affected in Chagas disease; 25 to 30% of the infected cases develop chagasic myocarditis that, if left untreated, leads to heart failure and sudden death (3) . Chagasic myocarditis is characterized by dilated myocardiopathy and subsequent alterations of cardiac functions. At the tissue level, it is characterized by myocardial remodeling and associated mononuclear cell infiltration (3) . It is intriguing, however, that there is no clear correlation between the presence of T. cruzi in the cardiac tissue and the development of chagasic myocardiopathy (4) .
The origin of chagasic myocardiopathy has been addressed by two theories: the neurogenic theory postulates that myocardiopathy emerges as the result of an autonomic unbalance. In this scenario, the sympathetic activity predominance is a direct consequence of the loss of parasympathetic input, due to selective and irreversible destruction of the postganglionic vagal neurons, a phenomenon that occurs during the acute phase of infection (5, 6) . The immunogenic theory postulates that the onset of chagasic myocardiopathy is the direct consequence of an inflammatory response. The myocardial inflammatory infiltrate is the source of a variety of immune mediators, such as neutralizing antibodies and pro-inflammatory cytokines. Immunologic insults can modulate cardiac function by causing direct muscle remodeling associated with modulation of the β-adrenergic receptor-associated adenylylcyclase activity (7) (8) (9) (10) . Similarities between T. cruzi epitopes and human cardiomyocyte receptor epitopes such as β-adrenergic receptors, M 2 -subclass muscarinic acetylcholine receptor (mAChR), nicotinic cholinergic receptors, and certain voltage-dependent channels have been described (11) (12) (13) (14) (15) .
Antibodies directed at T. cruzi antigens, especially those of the IgG class, can act as cholinergic mAChR agonists, reducing atrial contractility and triggering classic mAChR signal transduction outcomes (i.e., cGMP stimulation or cAMP inhibition). Atropine neutralizes these effects by direct competition for the mAChR binding sites, while pertussis toxin acts by preventing the inhibition of cAMP (16) . It has been reported that serum from chronic chagasic patients with complex cardiac arrhythmias is able to reduce cardiac rate (17) and induce auricular-ventricular conduction blockades, in isolated beating heart preparations, which is partially antagonized by atropine (18) . Furthermore, the relationship between the immune system and the muscarinic cholinergic system is suggested by the report that activation of mAChR expressed on T cell receptor-activated T cells increases the production of IL-2 (19) .
The neurogenic theory predicts that the consequences of parasympathetic denervation should be a muscarinic cholinergic receptor population up-regulation; however, according to the immunogenic theory, putative agonistic activity of the autoantibodies should induce mAChR subsensitivity and desensitization (20) . Even though there is strong evidence in favor of both neurogenic and immunogenic theories, some investigators have failed to demonstrate mAChR up-or down-regulation. Torres et al. (21) observed that the mAChR function is neither depressed nor enhanced during the acute stage of Chagas disease in rats. Similarly, Tanowitz et al. (22) did not observe changes in the mAChR number or function in the heart of T. cruzi-infected mice.
In the present investigation, we analyzed the status of mAChR in a rat model of chronic Chagas disease. We evaluated 1) mAChR ex vivo expression in heart muscle and in peripheral blood mononuclear cells (PBMC), and 2) serum levels of pro-inflammatory cytokines in infected animals. Also, using primary cardiomyocytes co-cultured with autologous PBMC and T. cruzi we evaluated 1) mAChR expression in vitro, and 2) the levels of pro-inflammatory cytokines in the culture medium.
Material and Methods

Animal model
Three-week-old male Sprague Dawley rats, obtained from the Instituto Venezolano de Investigaciones Científicas (IVIC) animal facilities, were divided into experimental (N = 29) and control groups (N = 36). The experimental animals were inoculated intradermally with metacyclic trypomastigotes suspended in 0.9% NaCl, at a dose of 1000 trypomastigotes per gram of body weight. The T. cruzi MHOM/ VE/92/2-92-YBM strain (23, 24) used in these experiments was isolated from the dejections of laboratory-infected Rhodnius prolixus. The control animals were inoculated with a suspension of dejections of healthy R. prolixus diluted in 0.9% NaCl achieving the same concentration as the inoculum of laboratory-infected R. prolixus dejections. All animals were tested for parasitemia levels biweekly and K. Peraza-Cruces et al.
www.bjournal.com.br those animals belonging to experimental group that tested negative were excluded. After 6 months of infection and under general anesthesia (40 mg/kg pentobarbital), 8-12 mL blood was collected from the abdominal aorta of each animal and the heart was removed for dissection of selected regions (i.e., atria, septum, and both ventricles). All animal studies were carried out in conformity with the American Physiological Society Guiding Principles in the Care and Use of Laboratory Animals (25) .
Serum and PBMC isolation
Non-heparinized blood (4 mL) was allowed to clot at room temperature and the resulting serum was inactivated at 60°C for 30 min. For PBMC isolation, 4 mL heparinized whole blood was diluted 1:1 (v/v) in cold balanced saline solution (BSS: 5 µM CaCl 2 , 0.98 µM MgCl 2 , 5.4 mM KCl, 14.5 mM Tris buffer, 0.126 M NaCl, and 5.56 mM Dglucose), loaded onto a 4-mL Ficoll-Paque ® cushion (Amersham Pharmacia Biotech, UK) and centrifuged at 1000 g for 1 h at 5°C. The PBMC layer (buffy coat) was carefully recovered, diluted in 5 mL cold BSS, and centrifuged at 1000 g for 30 min at 5°C. The resulting pellet was resuspended in RPMI medium supplemented with 10% homologous rat serum, 100 IU/mL penicillin and 0.1 mg/mL streptomycin. Cell number and viability was determined by Trypan blue exclusion.
Cardiomyocyte cultures
Hearts were removed from 1-day-old Sprague Dawley rats under general anesthesia (40 mg/kg pentobarbital) and antiseptic conditions. They were rinsed in cold Ca 2+ /Mg 2+ free Hank's balanced saline solution, minced and dissociated with 1 mg/mL collagenase (Worthington Biochemical Corporation, USA) at 37°C for 40 min. Collagenase activity was terminated by adding fetal bovine serum (FBS; 20% final concentration). Dissociated cardiomyocytes were seeded at a density of 1.5-2 x 10 5 cells/mL on laminin-coated 35 x 10 mm dishes in complete basal medium Eagle (BME; Gibco Invitrogen Corporation, USA) supplemented with 10% FBS, 100 IU/mL penicillin, and 0.1 mg/mL streptomycin, and incubated at 37°C in a 5% CO 2 incubator. After 24 h, the culture medium was totally replaced with fresh complete BME and after that only 50% of the medium was replaced twice a week. Cardiomyocyte cultures were assayed on the 4th or 7th days of culture.
Transmembrane cultures of cardiomyocytes and T. cruzi/PBMC co-cultures
Parasites (2 x 10 5 ) and PBMC (5 x 10 5 ) were co-seeded in an upper transmembrane Millicell ® chamber (Millipore Corporation, USA) and co-cultured with 4-day-old cardiomyocytes seeded on the bottom of the main chamber. After 48 h, co-culture media were collected and stored at -70°C. The cardiomyocyte layer was scraped, homogenized, and stored at -70°C until further use. Protein content was determined using a modification of Lowry's method (26).
Protein synthesis
[ 3 H]-leucine (5 µCi; Amersham Pharmacia Biotech) was added to 1-week-old cardiomyocyte cultures concomitantly with 10 µM cytarabine to inhibit cellular proliferation. After 24-h incubation at 37°C in a 5% CO 2 incubator, cells were washed three times with 2 mL ice-cold BSS. Cell integrity was disrupted by incubating them with 2 mL 10% trichloroacetic acid for 10 min at 4°C following the addition of 2 mL 100% methanol. Preparations were allowed to air-dry before adding 1 mL 0.3 N NaOH, 1% SDS solution and further incubated for 30 min. Solubilized cell preparations (400 µL) were assessed for [ 3 H]-leucinedependent radioactivity levels in a liquid scintillation counter (57% counting efficiency; Wallac 1410, Pharmacia, Inc., Finland). Total protein levels were also determined as indicated above.
Cytokine determination
IL-6, IL-1β, and TNF-α levels were assessed using commercial ELISA kits, following manufacturer instructions (Biosource Europe S.A., Belgium, http://www.biosourcediagnostics.com/catalog/default.asp?categ=50). Intra-assay coefficients of variation were 5.2% for IL-6, 4.5% for TNF-α and 2.8 for IL-1β. Interassay coefficients of variation were 9% for TNF-α, 9.9% for IL-6, and 4.5% for IL-1β.
[ 3 H]-QNB binding assay
Receptor density was measured in quadruplicate in homogenates from isolated cardiomyocytes, PBMC, or selected cardiac regions (atrium, septum, right and left ventricles), using saturating concentrations of [ 3 H]-quinuclidinylbenzilate ([ 3 H]-QNB) in equilibrium binding assay conditions according to Perez et al. (27) .
Data analysis
Data are reported as means ± SEM. Differences between control and experimental subjects were analyzed by the Student t-test and P < 0.05 was considered to be statistically significant.
Results mAChR expression in T. cruzi-infected rat cardiomyocytes
Using saturating concentrations of [ 3 H]-QNB (500 pM), we determined the number of mAChR (specific binding:
Muscarinic receptor expression in Chagas disease rat models www.bjournal.com.br moles of bound [ 3 H]-QNB per mg of protein) in atrium, interventricular septum, and ventricle homogenates from both chagasic and control rats, which displayed similar mAChR density (Table 1) . However, the mAChR density was 23% higher in the right ventricle of T. cruzi-infected rats (72.29 ± 5.79 fmol/mg) compared with control (58.69 ± 5.54 fmol/ mg; P < 0.05; Table 1 ).
mAChR expression in cultured cardiomyocytes
Cardiomyocytes co-cultured with chagasic rat PBMC and T. cruzi trypomastigotes displayed a significantly higher (P < 0.05) mAChR density (43.62 ± 5.08 fmol/mg; N = 7) than those cardiomyocytes co-cultured with healthy rat PBMC and T. cruzi trypomastigotes (24.33 ± 3.83 fmol/mg; N = 7) ( Table 2 ). In order to show that these results are due to soluble molecules secreted by the parasites or by the PBMC as a consequence of cell-parasite interactions, we prepared cardiomyocyte cultures using conditioned medium from 2-day-old chagasic or healthy PBMC/T. cruzi cocultures and tested the cardiomyocyte mAChR density. Cardiomyocytes cultured with conditioned medium from chagasic PBMC/T. cruzi showed increased (P < 0.05) mAChR density (54.38 ± 6.28 fmol/mg; N = 20) compared with the receptor density detected in cardiomyocytes cultured in conditioned medium derived from non-chagasic PBMC/T. cruzi co-cultures (37.84 ± 3.84 fmol/mg; N = 4).
Protein expression in cardiomyocytes and PBMC
First, we determined the effect of chagasic or healthy rat serum on the total protein expression in cardiomyocytes, and we observed increased (P < 0.05) total protein expression in cardiomyocytes cultured with chagasic rat inactivated serum (0.92 ± 0.1 mg/mL; N = 4) compared with control cultures (0.59 ± 0.08 mg/mL; N = 4). We determined the total protein content in cardiomyocytes from transmembrane cultures and we found that cardiomyocytes co-cultured with chagasic rat PBMC/T. cruzi trypomastigotes expressed higher protein levels (2.31 ± 0.20 mg/plate; N = 8) compared with the cardiomyocytes cocultured with healthy rat PBMC and T. cruzi trypomastigotes (1.70 ± 0.09 mg/plate; N = 6; P < 0.05; Table 2 ). The protein synthesis rate, measured by [ 3 H]-leucine uptake, indicated that cardiomyocytes cultured with chagasic-conditioned medium have an elevated protein synthesis rate (21,030 ± 2321 dpm; N = 7) compared with those cardiomyocytes cultured with healthy conditioned medium (10,940 ± 2385 dpm; N = 7; P < 0.05).
mAChR density and protein expression in healthy or chagasic rat non-activated PBMC
Total protein levels were significantly different between chagasic PBMC homogenates (2.07 ± 0.32 mg/mL; N = 7) and control PBMC homogenates (3.31 ± 0.37 mg/mL; N = 7; P < 0.05; Table  2 ). Interestingly, the changes in mAChR density, as demonstrated by binding assays, did not parallel those changes observed in total protein levels. Chagasic PBMC preparations presented higher mAChR density (20.22 ± 1.82 fmol/mg protein; N = 19) than the control (12.88 ± 2.45 fmol/mg protein; N = 18; P < 0.05; Table 2 ).
Cytokine levels in chagasic rat plasma and PBMC/T. cruzi co-culture media IL-6, IL-1β and TNF-α levels in vivo (plasma) and in vitro (PBMC/T. cruzi co-cultures media) were selectively disregulated. As shown in Table  3, , , , , IL-1β serum levels were elevated in chagasic rat plasma compared with control animals (9.15 ± 2.08 and 3.38 ± 0.59 pg/mL, respectively; N = 10; P < 0.05). IL-1β concentration also appeared elevated in the PBMC-T. cruzi culture media (16.54 ± 4.42 vs 6.76 ± 1.34 pg/mL, respectively; N = 10, P < 0.05). IL-6 levels were significantly elevated in chagasic PBMC/T. cruzi co-culture media (21.86 Data are reported as means ± SEM. A = atrium; IVS = inter-ventricular septum; LV = left ventricle; RV = right ventricle. *P < 0.05 compared to control (Student t-test). ± 3.15 vs 11.64 ± 1.06 pg/mL, respectively; N = 10; P < 0.05), but there were no significant changes in chagasic animal serum in vivo. TNF-α levels were significantly lower in the chagasic PBMC/T. cruzi cultures (59.39 ± 3.56 vs 71.47 ± 2.77 pg/mL, respectively; N = 10; P < 0.05) but no changes were detected in chagasic animal serum in vivo (Table 3) .
Discussion
The main objective of this study was to determine whether there are changes in the expression of cardiac mAChR in in vitro and in vivo Chagas disease models. Our results demonstrate the up-regulation of cardiomyocyte muscarinic receptors when these cells were cultured with PBMC/T. cruzi co-cultures. There was also an increase of IL-6 and IL-1β levels in the culture media. However, in our in vivo model, the up-regulation of mAChR was partially observed only in the right ventricle.
The participation of the muscarinic cholinergic system in the development of chagasic cardiomyopathy is supported by both the neurogenic (6) and the autoimmune theories (11) . During the acute phase of Chagas disease, the post-ganglionic vagal neurons of the intra-cardiac plexus are selectively destroyed by either T. cruzi cell invasion or by auto-antibodies directed to membrane structures (5,6). The result of either insult should promote the development of functional supersensitivity and/or up-regulation of postsynaptic mAChR in the cardiac muscle, due to a denervation phenomenon. Rocha et al. (28) observed that C57BL/ 6 mice that have been inoculated intraperitoneally with T. cruzi trypomastigotes have an increased cardiac muscarinic receptor density 8 months after infection. In our in vivo chagasic rat model, the up-regulation of mAChR was restricted to the right ventricle from chronic chagasic adult rat heart, which suggests a selective denervation of the right ventricle vagal fibers. However, this explanation is not sufficient to explain the mAChR supersensitivity observed in the cardiomyocytes/PBMC-T. cruzi co-cultures where nervous input is absent.
The possible agonistic activity of some anti-muscarinic and/or anti-nicotinic cholinergic receptor antibodies (11, 12, 17) could induce receptor functional subsensitivity and down-regulation of the post-synaptic cardiac muscle mAChR, due to an agonist-induced receptor desensitization phenomenon (20) ; however, this event in cardiac tissues of chagasic animals has not been observed or reported. In the scenario in which both phenomena (vagal denervation and muscarinic receptor modulation by autoantibodies) are supposed to occur simultaneously, each phenomenon could neutralize the other with no overall changes in mAChR expression. This explains the absence of mAChR supersensitivity in the other cardiac regions (atrium, septum, and left ventricle) observed in the present investigation in our in vivo rat model. Our observations are consistent with Tanowitz and colleagues (22), who reported no significant changes in the number and kinetics properties (Kd and Bmax) of the mAChR 22 of chagasic mice on the acute phase of the disease. Similarly, Torres et al. (21) , working on chagasic Wistar rats in the acute or subacute phase of the disease, also failed to demonstrate any significant cardiac mAChR supersensitivity.
We observed that cardiomyocytes cultured in vitro with PBMC and T. cruzi, in a trans-well system, exhibited enhanced protein synthesis and up-regulation of their mAChR population. These enhanced parameters could be the result of soluble factors produced by T. cruzi-activated PBMC, which are able to modulate mAChR and other protein expression, as was suggested in the present study. Previously, it has been reported that pro-inflammatory cytokines are able to regulate mAChR expression, i.e., in human embryonic lung fibroblasts, transforming growth factor β1 (TGF-β1), TNF-α, and IL-1β have been associated with M 2 -subclass mAChR desensitization (29) . Similarly, using HEL 299 cells it has been reported that TNF-α and IL-1β synergistically down-regulate M 2 -subclass mAChR at the protein and mRNA levels (30) . Moreover, incubation of embryonic chicken heart cells with TGF-β1 Table 3 . Table 3 . Table 3 . Table 3 . Table 3 . Cytokine levels in plasma and culture medium. Data are reported as means ± SEM for N = 10. Culture medium was taken from transmembrane cultures of cardiomyocytes and peripheral blood mononuclear cell/Trypanosoma cruzi co-cultures. *P < 0.05 compared to control (Student t-test).
Muscarinic receptor expression in Chagas disease rat models www.bjournal.com.br resulted in a concentration-and time-dependent downregulation of the mAChR transcriptional and translational products, explaining the observed refractory response to carbachol-mediated inhibition of adenylylcyclase activity (31) . Also, up-regulation of the M 3 -subclass mAChR and CCK-A receptor expression, concomitantly with the elevation of plasma IL-6 levels, was described in a bile-pancreatic juice exclusion from constriction-induced acute pancreatitis in rats (32) . Our finding that up-regulation of the cardiac mAChR population could be the consequence of increased local levels of pro-inflammatory cytokines such as IL-6 is consistent with these observations. Our results demonstrated a significant up-regulation on the right ventricle mAChR population, suggesting that mAChR supersensitivity is a response to cytokines released by inflammatory cells involved at the myocarditis sites. This idea is supported by our in vitro model of cardiomyocytes trans-well cultured with PBMC-T. cruzi cocultures. In this in vitro system the up-regulation of the muscarinic receptors was parallel to high IL-6 and IL-1β, but low TNF-α levels detected in the culture-conditioned media, suggesting a modulator effect of these cytokines on the cardiac tissue muscarinic receptor population.
The importance of the integrity of the cholinergic system in the development of Chagas disease myocardiopathy is still controversial. The development of alterations in mAChR expression and/or function and their role in the pathogenesis of the chagasic cardiac dysfunction could be related to the presence of circulating antibodies against these receptors. It has been reported that patients in the early stages of Chagas disease have circulating autoantibodies to the muscarinic receptors, associated with abnormal modulation of vagal activity (33) . Furthermore, serum from chagasic patients is reported to have a muscarinic agonistic activity, evoking strong ventricular re-polarization rhythm disorders (34) . Administration of the antiparasitic drug benznidazole during the chronic phase of Chagas infection prevents the development of a more severe form of chronic cardiomyopathy. The amelioration of the cardiac pathology occurs concomitantly with a decrease in the levels of antibodies to the cardiac M 2 -muscarinic receptors (35) . Likewise, heart dysfunction is prevented in mice infected with Tulahuen T. cruzi trypomastigotes if they are treated with an M 2 mAChR immunogenic peptide (36) . However, there is no clear correlation between the detectable auto-antibody levels and the clinical parameters of ventricular dysfunction (37) .
Mononuclear cell-derived cytokines have also been involved in the development of cardiac tissue remodeling and heart failure (7, 8) . Studies on the participation of cytokines in Chagas disease evolution suggest that while IL-2 and IFN-γ have protective effects during the acute phase of the disease by decreasing the parasite load, TNF-α and IL-10 are associated with an exacerbation of the cardiac damage (38) . Studies conducted on Chagas disease patients revealed a correlation between increased serum levels of TNF-α (39) or IL-6 (40) with progression of the disease to more severe clinical stages.
Increased plasma levels of IL-6 must be a consequence of increased heart inflammatory foci indicative of severe damage of postganglionic vagal neurons, which allows adrenergic hyperactivity and muscle mAChR supersensitivity. According to the neurogenic theory, the cardiac autonomic nervous system falls off balance with sustained sympathetic activity, which is the major contributing factor for the progressive deterioration of cardiac function (5).
Our results provide arguments favoring the concept that during Chagas disease evolution, PBMC supply high levels of pro-inflammatory cytokines, such as IL-6 and IL-1β, which could modulate cardiomyocyte mAChR expression. Increased pro-inflammatory cytokine plasma levels could have origin in diffused heart inflammatory foci, associated or not with postganglionic vagal neuron damage and thus, adrenergic hyperactivity and muscle mAChR supersensitivity.
